Epigral Share Price
1228.00-8.70 (-0.70%)
-31.87% past 1 Year
Epigral Limited (Formerly known as Meghmani Finechem Limited) is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The company is also engaged in trading of Agrochemical
Corporate filings & documents
Announcements
Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday 03.09.2026
3 days agoEpigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday 03.09.2026
3 days agoEpigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday 20.08.2026
2 weeks agoEpigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday 20.08.2026
2 weeks agoEpigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August 2026
3 weeks agoEpigral Limited hereby informs that the officials of the Company are participating in EMKAY Confluence 2026 on 12th August 2026
3 weeks agoEpigral Limited informs that the Company is having One-on-One Meeting with Investor / Analyst on Monday 3rd august 2026.
1 month agoEpigral Limited informs that the Company is having One-on-One Meeting with Investor / Analyst on Monday 3rd august 2026.
1 month agoEpigral Limited submits Transcript of Conference Call discussing Q1 FY27 Results.
1 month agoEpigral Limited submits Transcript of Conference Call discussing Q1 FY27 Results.
1 month agoNewpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
1 month agoNewpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
1 month agoNewspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026
1 month agoAudio Recording of Conference Call discussing Q1 FY27 Results held on Monday 27th July 2026 at 5.00 p.m.
1 month agoAudio Recording of Conference Call discussing Q1 FY27 Results held on Monday 27th July 2026 at 5.00 p.m.
1 month agoInvestor Presentation Q1 FY 27.
1 month agoInvestor Presentation Q1 FY 27.
1 month agoPress Release of Un-Audited Financual results - Q1FY27.
1 month agoPress Release of Un-Audited Financual results - Q1FY27.
1 month agoAs part of the Companys strategic growth and expansion initiatives it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its existing facility at Dahej Gujarat.
1 month agoAs part of the Companys strategic growth and expansion initiatives it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its existing facility at Dahej Gujarat.
1 month agoOutcome of Board Meeting held on Monday 27th July 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June 2026.
1 month agoOutcome of Board Meeting held on Monday 27th July 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended 30th June 2026.
1 month agoUNAUDITED FINANCIAL RESULTS - 30.06.2026.
1 month agoUNAUDITED FINANCIAL RESULTS - 30.06.2026.
1 month agoEpigral Limiteds reply to clarification sought by the Stock Exchange with reference to Movement in Volume.
1 month agoEpigral Limiteds reply to clarification sought by the Stock Exchange with reference to Movement in Volume.
1 month agoEpigral Limited has informed the Exchange about Conference Call on Monday 27th July 2026 to discuss Q1 FY27 Results
1 month agoEpigral Limited has informed the Exchange about Conference Call on Monday 27th July 2026 to discuss Q1 FY27 Results
1 month agoThe Exchange has sought clarification from Epigral Ltd on July 22 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
1 month agoThe Exchange has sought clarification from Epigral Ltd on July 22 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
1 month agoEpigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June 2026.
1 month agoEpigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June 2026.
1 month agoRevised Credit Rating.
1 month agoRevised Credit Rating.
1 month agoEpigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026
1 month agoEpigral Limited submits certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026
1 month agoEpigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".
1 month agoEpigral Limited has informed the Exchange about Incorporation of a Wholly owned Subsidiary namrly "Epigral Advanced Materials Limited".
1 month agoEpigral Limited submits Notice of Closure of Trading Window
2 months agoEpigral Limited submits Notice of Closure of Trading Window
2 months agoEpigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on June 16 2026.
2 months agoSubmission of Scrutinizers Report of 19th AGM held on 08.06.2026.
2 months agoSubmission of Scrutinizers Report of 19th AGM held on 08.06.2026.
2 months agoProceedings of 19th AGM held on 08.06.2026.
2 months agoEpigral Limited submit Review of CRISIL Ratings on the Bank Facilities of Epigral Limited.
3 months agoAnnual Secretarial Compliance Report - 31.03.2026.
3 months agoAnnual Secretarial Compliance Report - 31.03.2026.
3 months agoPostal Ballot - Scrutinizers Report and Outcome.
3 months agoEpigral Limited submits Newspaper Publication pertaining to 19th Annual General Meeting and Record Date for Dividend and E-Voting
3 months agoAnnual reports
Concalls & investor presentations
Jul 2026
May 2026
Jan 2026
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
Jan 2025
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Jul 2024
Apr 2024
Jan 2024
Nov 2023
Aug 2023
ConcallPresentation
Apr 2023
Jan 2023
Oct 2022
Jul 2022
Apr 2022
Jan 2022
Nov 2021
ConcallPresentation
Oct 2021
Aug 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-06-01
Dividend
5.0
2025-06-20
Dividend
3.5
2025-02-07
Dividend
2.5
2024-07-02
Dividend
5.0
Company details
Registered office
‘ Epigral Tower’ Behind Safal Profitaire, Corporate Road Nr. Auda Garden, Prahlad Nagar Ahmedabad Gujarat PIN: 380015 Tel No: 079-71761000 / 29709600 Fax No: 079-29709605 Email: [email protected] Internet: www.epigral.com
Registrars
5th Floor, 506 to 508,Amarnath BusinessCentre-1(Abc-1), Beside Gala Business Center, Nr. St. Xavier’s CollegeCorner, Off C G Road, Ellis bridge, Ahmedabad - 380006 5th Floor, 506 to 508,Amarnath Business Centre-1(Abc-1), Beside Gala Business Center Nr. St. Xavier’s College, Corner, Off C G Road, Ellis Bridge PIN: Tel No: NULL Fax No: NULL Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Maulik Patel, Chairman & Managing Director
Maulik Patel, Chairman & Managing Director
Kaushal Soparkar, Executive Director
Karana Patel, Non Independent & Non Executive Director
Ankit Patel, Non Independent & Non Executive Director
Darshan Patel, Non Independent & Non Executive Director
Manubhai Patel, Non Executive Independent Director
Sanjay Asher, Non Executive Independent Director
Kanubhai Patel, Non Executive Independent Director
Raju Swamy, Non Executive Independent Director
Priyanka Chopra, Non Executive Independent Woman Director
Gaurang Trivedi, Company Secretary & Compliance Officer
Details
BSE 543332
NSE EPIGRAL
ISIN INE071N01016